Octostim Dosierspray (Desmopressin Acetate)

Desmopressin Acetate, the active ingredient in Octostim Dosierspray, is an antidiuretic hormone (ADH) analog presented as a dosage spray for intranasal use. It is employed to manage conditions related to water balance and certain bleeding disorders in both children and adults.

GNH USA supplies Octostim Dosierspray as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Desmopressin Acetate acts on the vasopressin pathway to control water reabsorption and coagulation factors. - Central diabetes insipidus: reduces excessive urine output and helps normalize fluid balance. - Nocturnal enuresis: decreases nighttime bladder pressure and frequency of bed‑wetting episodes. - Mild hemophilia A and mild von von Günzburg disease: raises plasma levels of factor VIII and vWF, improving clot formation.

Desmopressin may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Headache: mild to moderate intensity. - Nasal irritation: burning or itching at the spray site. - Hyponatraemia: low blood sodium, often asymptomatic. - Flushing: transient warmth or redness of the skin. - Nausea: occasional upset stomach. - Mild hypotension: slight drop in blood pressure.

Serious or Rare Side Effects: - Seizures: associated with severe hyponatraemia. - Thromboembolic events: clot formation in deep veins or pulmonary arteries. - Severe hyponatraemia: may cause cerebral oedema. - Allergic reactions: rash, pruritus, or anaphylaxis. - Cardiac arrhythmias: irregular heart rhythm linked to electrolyte shifts.

Desmopressin requires careful monitoring of fluid balance and electrolytes, especially in at‑risk populations. - Fluid restriction: limit intake to ≤1.5 L/24 h in patients prone to hyponatraemia. - Electrolyte monitoring: check serum sodium regularly during therapy. - Cardiovascular disease: use cautiously in patients with heart failure or uncontrolled hypertension. - Pregnancy and lactation: evaluate risk‑benefit, as safety data are limited. - Age considerations: dose adjustments may be needed for elderly patients. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Desmopressin can interact with several drug classes, altering its efficacy or safety profile.

Major Interactions (Avoid): - NSAIDs: increase risk of hyponatraemia and renal impairment. - Antifreeze (vasopressin antagonists): negate desmopressin’s antidiuretic effect. - Carbamazepine: may enhance hyponatraemia risk.

Moderate Interactions (Monitor Closely): - Diuretics (especially thiazides): potentiate water retention and hyponatraemia. - Selective serotonin reuptake inhibitors (SSRIs): modestly raise hyponatraemia risk. - Hormonal contraceptives: may affect fluid balance, requiring closer observation.